The market for tissue microarrays (TMA) is set to grow at 42% per year from $13 million in 2002 to almost $163 million in 2008, according to a new report by Select Biosciences Ltd.

Prepared in San Francisco , California by Dr Martina Werner, Tissue Microarrays : Market Assessment and Opportunities presents a detailed market model and thorough analysis of the technologies and business strategies of 22 leading TMA companies. 

The report is based on extensive primary and secondary research and discusses the background of the main market applications :

• Morphology
• Gene Copy Number
• Gene Expression
• Protein Expression and Localization
• Target/ Biomarker Discovery & Validation
• Drug Development / Clinical Trials
• Assay Development / Quality Control

In-depth information on the market and size segmented by technology and application is revealed.

In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.

Select Biosciences Ltd., is a strategic consulting firm that specializes in emerging markets and technologies in biotechnology and pharmaceuticals. Including several leading authorities, our consultants prepare business analyses and reviews, and have presented work at many biomedical conferences. 

Click the title to order RNAi 2004: Strategic Opportunities

http://www.bioportfolio.com/cgi-bin/acatalog/select_bioscience.html